NCT04069637

Brief Summary

The investigators are conducting research to compare serum and urine titanium levels in children with early onset scoliosis who are being treated with certain types of metal spinal rods. These rods include traditional growing rods (TGR), magnetically-controlled growing rods (MCGR), and Vertical Expandable Prosthetic Titanium Rib (VEPTR). Children with metal rods may have elevated serum and urine titanium levels. These levels may remain elevated over time. The investigators will collect serum titanium levels from children with metal rods and children without metal rods to see if there are differences in their titanium levels. The investigators will then collect a second serum titanium level from children with metal rods at least 6 months later to see if the participants titanium levels remain elevated over time. The investigators will also collect urine titanium levels from children with metal rods to see if titanium is excreted in the urine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 23, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

November 7, 2019

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 19, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 19, 2022

Completed
Last Updated

July 22, 2022

Status Verified

July 1, 2022

Enrollment Period

2.7 years

First QC Date

August 23, 2019

Last Update Submit

July 21, 2022

Conditions

Keywords

Titanium Levels

Outcome Measures

Primary Outcomes (3)

  • Serum titanium levels between groups

    Compare serum titanium levels in patients with EOS treated with titanium alloy TGR, MCGR, and VEPTR to age-matched controls.

    At enrollment

  • Serial serum titanium levels in scoliosis patients

    Collect serial serum titanium levels in patients with EOS treated with TGR, MCGR, and VEPTR.

    Roughly 6 months apart

  • Urine titanium levels in scoliosis patients

    Collect urine titanium levels in patients with EOS treated with TGR, MCGR, and VEPTR.

    At enrollment

Study Arms (2)

Early onset Scoliosis

Patients with early onset scoliosis treated with growth-sparing instrumentation (TGR, MCGR, and, VEPTR).

Combination Product: Growth-sparing instrumentation and titanium levels

Control group

Patients with operative fractures.

Interventions

Patients with growth-sparing instrumentation as treatment for early onset scoliosis, will have their titanium (serum and urine) levels tested, to evaluated if they have elevated titanium levels compared to a control group.

Early onset Scoliosis

Eligibility Criteria

Age5 Years - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population will be patients treated by the Pediatric Orthopaedic Surgery department at Michigan Medicine.

You may qualify if:

  • Cases: Patients with early onset scoliosis treated with traditional growing rods (TGR), magnetically controlled growing rods (MCGR), and the Vertical Expandable Prosthetic Titanium Rib (VEPTR).
  • Controls: Patients with operative fractures.

You may not qualify if:

  • Cases: Patients who had a previous limited spinal fusion, conversion from one type of GSI to another, TGR with stainless steel or cobalt chromium instrumentation, and indwelling implants for 6 months or less.
  • Controls: Patients with indwelling implants or prior implant insertion and removal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michigan Medicine

Ann Arbor, Michigan, 48109, United States

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor Of Orthopaedic Surgery

Study Record Dates

First Submitted

August 23, 2019

First Posted

August 28, 2019

Study Start

November 7, 2019

Primary Completion

July 19, 2022

Study Completion

July 19, 2022

Last Updated

July 22, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations